JB Pharma forays into Statin segment, acquires Razel franchise from Glenmark for Rs 314 crore Ruchika Sharma15 Dec 2022 4:00 PM ISTNew Delhi: JB Pharma, one of the fastest growing pharmaceutical companies in India, has entered into an agreement with Glenmark Pharmaceuticals...
Glenmark Pharma Goa facility gets USFDA warning letter Ruchika Sharma12 Dec 2022 11:33 AM ISTThe US health regulator also pointed out that the company failed to prepare batch production and control records with complete information relating to...
Glenmark Pharma settles with Pfizer for Axitinib Tablets Ruchika Sharma22 Nov 2022 2:30 PM ISTMumbai: Glenmark Pharmaceuticals Inc., USA (Glenmark) and Glenmark Pharmaceuticals Limited have reached a settlement agreement with Pfizer ...
Glenmark Pharma profit after tax rises marginally to Rs 279 crore in Q2 Ruchika Sharma13 Nov 2022 12:00 PM ISTNew Delhi: Drugmaker Glenmark Pharmaceuticals on Friday said its profit after tax (PAT) rose marginally to Rs 279 crore for the second quarter...
Glenmark unveils generic version of Gilenya Capsules in US Ruchika Sharma2 Nov 2022 2:30 PM ISTMumbai: Drugmaker Glenmark Pharmaceuticals Inc., USA, has recently announced the launch of Fingolimod Capsules, 0.5 mg in the US. The...
Glenmark Baddi facility placed under import alert by USFDA Ruchika Sharma28 Oct 2022 11:28 AM ISTGlenmark said it will engage with the agency to resolve the import alert at the earliest.
Glenmark Pharma unveils Teneligliptin plus Dapagliflozin FDC for type 2 diabetes Ruchika Sharma22 Oct 2022 11:00 AM ISTGlenmark’s Zita D is priced at around Rs 14 per tablet for FDC of Teneligliptin 20mg + Dapagliflozin 5mg, and Rs 15 per tablet for FDC of...
Glenmark Specialty, Hikma Pharma launch seasonal allergic rhinitis nasal spray in US Roshni Dhar31 Aug 2022 5:39 PM ISTHikma Pharmaceuticals PLC, the multinational pharmaceutical company, and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. have...
Glenmark Specialty, Hikma Pharma launch seasonal allergic rhinitis nasal spray RYALTRIS in US Ruchika Sharma31 Aug 2022 1:30 PM ISTThe onset of action for nasal symptom relief occurs within 15 minutes of a patient taking the first dose.
Glenmark Pharma North Carolina facility gets USFDA OAI status Ruchika Sharma25 Aug 2022 11:55 AM ISTMumbai: Glenmark Pharmaceuticals Limited has recently announced that the company has received Official Action Indicated (OAI) status from the US Food...
Cipla, Glenmark and 1 other recall products in US over manufacturing issues Ruchika Sharma22 Aug 2022 11:23 AM ISTAs per the USFDA, homegrown drug major Cipla is recalling 7,992 bottles of Difluprednate Ophthalmic Emulsion, used to treat swelling and pain after...
Sun Pharma, Dr Reddy's Labs and 2 others recall products in US Ruchika Sharma16 Aug 2022 11:38 AM ISTAs per the USFDA, Sun Pharma is recalling 9,552 bottles of epilepsy treatment drug Divalproex Sodium delayed-release tablets due to "Failed...
